Neovasc Inc. Non-operating Interest Expenses

Non-operating Interest Expenses of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Interest Expenses growth rates and interactive chart. Interest expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from interest expenses.


Highlights and Quick Summary

  • Non-operating Interest Expenses for the quarter ending March 31, 2022 was $350 Thousand (a 25.33% increase compared to previous quarter)
  • Year-over-year quarterly Non-operating Interest Expenses increased by 25.74%
  • Annual Non-operating Interest Expenses for 2021 was $631 Thousand (a -39.07% decrease from previous year)
  • Annual Non-operating Interest Expenses for 2020 was $1.04 Million (a 678.36% increase from previous year)
  • Annual Non-operating Interest Expenses for 2019 was $133 Thousand (a -23.72% decrease from previous year)
  • Twelve month Non-operating Interest Expenses ending March 31, 2022 was $941 Thousand (a 49.01% increase compared to previous quarter)
  • Twelve month trailing Non-operating Interest Expenses increased by 15.14% year-over-year
Trailing Non-operating Interest Expenses for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$941 Thousand $631 Thousand $659 Thousand $817 Thousand
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Interest Expenses of Neovasc Inc.

Most recent Non-operating Interest Expensesof NVCN including historical data for past 10 years.

Interactive Chart of Non-operating Interest Expenses of Neovasc Inc.

Neovasc Inc. Non-operating Interest Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.35
2021 $0.28 $0.03 $0.28 $0.04 $0.63
2020 $0.31 $0.19 $0.57 $-0.03 $1.04
2019 $0.1 $0.03 $0.13
2018 $0.17
2017 $0.37
2016 $0.17
2015 $0.0 $0.0 $0.0 $0.0 $0.0
2014 $0.0 $0.0 $0.0 $0.0 $0.01
2013 $0.0 $0.0 $0.0 $0.0 $0.01
2012 $0.0 $0.0 $0.0 $0.0 $0.01
2011 $0.01

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.